ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 59 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2017. The put-call ratio across all filers is 1.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $17 | -99.7% | 99,893 | +284.6% | 0.00% | – |
Q3 2022 | $5,000 | -96.3% | 25,970 | -88.4% | 0.00% | -100.0% |
Q4 2021 | $136,000 | -31.7% | 224,561 | +9.6% | 0.01% | -22.2% |
Q3 2021 | $199,000 | -39.0% | 204,870 | -40.8% | 0.02% | -21.7% |
Q1 2021 | $326,000 | +951.6% | 346,296 | +772.7% | 0.02% | +360.0% |
Q3 2020 | $31,000 | -27.9% | 39,683 | +92.7% | 0.01% | +150.0% |
Q1 2019 | $43,000 | -44.2% | 20,588 | -14.1% | 0.00% | -33.3% |
Q2 2018 | $77,000 | -82.6% | 23,963 | -76.1% | 0.00% | -87.0% |
Q4 2017 | $442,000 | – | 100,363 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenlight Capital | 1,000,000 | $1,100,000 | 0.07% |
Hayden Royal, LLC | 40,015 | $44,000 | 0.02% |
Verdence Capital Advisors LLC | 143,382 | $158,000 | 0.02% |
Founders Capital Management | 18,000 | $20,000 | 0.01% |
WOLFF WIESE MAGANA LLC | 10,740 | $12,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 1,622,510 | $1,785,000 | 0.01% |
Global Strategic Investment Solutions, LLC | 23,000 | $25,000 | 0.00% |
Stonebridge Capital Advisors LLC | 44,000 | $45,000 | 0.00% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $110,000 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 97,590 | $107,000 | 0.00% |